IMXI reported disappointing Q1 results and cut FY25 guidance. The stock fell 16% recently, with a current RSI of 20.8. Despite setbacks, CEO mentions resilient consumer base and growth. Potential breakout signals from Benzinga Pro may create buying interest. IMXI's recent price action indicates considerable market volatility.
Voss Capital seeks to maximize IMXI shareholder value through potential sale. IMXI trades under 5-times EBITDA, while peers have higher valuations. Voss may engage in proxy fight if strategic review fails to materialize.
- Intermex (IMXI) stock has gained 0.72% since February. - Operational developments support continued expansion for IMXI. - IMXI is currently estimated to be 35% undervalued in a DCF analysis. Price Impact Rating: Bullish Impact Horizon Rating: Long-term Type: Research Analysis
- IMXI reported quarterly earnings of $0.43 per share, beating estimates. - Company has surpassed EPS estimates three times in last four quarters. - IMXI shares down 11.3% YTD, Zacks Rank #3 (Hold) for stock. - Price Impact Rating: Bearish - Impact Horizon Rating: Short-term - Type: Earnings